I am a value-investor that looks for opportunities to exploit market inefficiencies to make outsized profits. Intense research, intelligence, and patience are the keys to having success in this strategy.
Founded by Dr. Hung Tran, MD, MS, CNPR, (in collaboration with Dr. Tran BioSci analyst, Ngoc Vu, and other PhDs), Integrated BioSci Investing (“IBI) marketplace research is delivering robust returns since inception. To name a couple winners, Nektar Therapeutics and Spectrum Pharmaceuticals delivered profits of 446% and 196% for our subscribers, respectively. Our secret sauce is extreme due diligence coupled with expert data analysis. The service features a once-weekly exclusive in-depth Integrated BioSci article (in the form of research, reports, or interviews), daily individual stocks consulting, and model portfolios. Of note, we’ll increase our price soon (SUBSCRIBE to IBI now to lock in the current price and save money). Click the orange FOLLOW button to receive the FREE real-time alerts on our articles and blogs. To read the FREE once-weekly articles covering promising small-cap bioscience firms, check out www.drtranbiosci.com (and make sure to register for our mailing list). You can read up on Dr. Tran’s background in an in-depth article by following this link. http://www.drtranbiosci.com/p/dr-tran.html "Stellar therapeutics for patients. Differentiated intelligence for investors. Premium valuations for firms."
John Gilliam holds a BBA from Millsaps College and a JD from the Cumberland School of Law. He is the manager of Point Clear Strategic Holdings in Point Clear, Alabama. Point Clear Strategic invests in value oriented small cap technology companies.
Visit: Point Clear Strategic Capital (http://www.pointclearstrategiccapital.com/)
Reuben has extensive experience in the capital markets, especially in emerging markets, fixed income, derivatives and futures, commodities, and investment banking (including private equity). He has taught on the University level in the US and has lectured undergrads in Hong Kong and tutored privately to undergrads and grad students both in NY and in Hong Kong. On a day to day basis he provides consulting and advisement to privately held micro-cap and middle market companies and top tier management consulting firms (as an Engagement Manager) not only in Asia, but worldwide as well. His independent resources and connections and extensive top tier financial service firm's experience allows him to bridge the gap between Western and Eastern business practices and cultures.
His specialties include sales and business development, developing and creating business plans, capital markets, trading and sales of fixed income, derivatives and commodities including energy products, conducting due diligence, financial analysis and modeling. He has been successful at capital raising, teaching, advising and mentoring, marketing, mergers and acquisitions and negotiations along with creative problem solving abilities, structured products and risk management. His industry focus has been telecommunications, technology and software, (including CRM), education and the beverage sector. He trades on a daily basis on many diverse global markets.
Founder of Albright Investment Group, MBA graduate, active investor, and entrepreneur. I have a B.S. in management, and an MBA with a specialization in finance from top tier universities. I've been investing since 2002, and I enjoy writing about companies and topics that interest me. I manage a private long equity and ETF fund, and a secondary hedging/trading portfolio. I also host a very successful research service on Seeking Alpha, Albright Investment Group.
I like to research and analyze dividend stocks and ETFs that are trending up at reasonable valuations using charts, some news and quarterly earnings report summaries. If I can get income from dividend yield, so much the better.
Tudor Investment Holdings Private Limited, is a Singapore based investment company. It's investments are in commercial real estate and managing a global portfolio of investments in equities and bonds. It's Director is Mr. Lasse Rochstad-Lim, who has extensive management experience in the bulk shipping and oil service industry. He also serve as a Director at TuffChem Environmental Services in Singapore. Mr. Rochstad-Lim is an Associate Sponsor Member of Securities Investors Association Singapore.
Seeking Alpha's product team is responsible for the development of all of our product-related projects from start to finish. These projects include the Seeking Alpha Portfolio apps on the App Store and Google Play, our Real Time email alert product, and optimization across the Seeking Alpha website.
The purpose of this profile is to allow us to share with our readers all new product developments. Please follow us on Seeking Alpha to receive updates. We look forward to your input and feedback!
SA Product Team
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
Kenneth Orr CEO, CIO and CRO – Series 65 Kenneth “Kenny” Orr is a graduate of Tufts University (’88 - Bachelor of Science) and completed case studies by Harvard Business School Executive Education Program - Concentration in Valuation and Strategic Acquisitions. Kenneth Orr joined a family-owned commodities trading firm called North American Agriculture Inc., and its sister company, Jake’s Products in 1988. Kenny’s roles included sourcing, buying and selling of physical commodities both domestically and internationally. In addition, Kenny led the acquisition of Jackson and Johnson, a leading ICC carrier in the northeastern United States, and sale of significant assets to cooperative Minnesota Corn Processors. During his tenure, which lasted five years, the company’s sales increased by 600 percent and the staff grew to 320 employees. Kenny became a shareholder in both companies. In 1993, Mr. Orr sold his interest in the companies and established his own investment banking firm. Kenny acquired Herold Securities in 1994. Herold was a Connecticut based broker dealer that focused on research. Kenny renamed the firm, First Cambridge Securities, and established offices in New York and Los Angeles, California. As chief executive Officer, Kenny built the firm to over 400 employees and more than 15,000 clients. Clearing through Bear Stearns, FCS quickly became one of Bear Stearns largest correspondents. FCS was an underwriter, syndicate member and or placement agent in billions of dollars’ worth of IPOs, secondary offerings and/or private placements. In addition to brokerage services, FCS maintained a proprietary trading desk, fixed income department and a research department. Co-underwriters and or syndicate members of FCS included Starr Securities, Fagenson & Co., Merrill Lynch, Bear Stearns, Montgomery, and Rausher Pierce. Notable under-writings and or initiated investment focus included, RentWay, which later sold to Rent-A-Center in 2003, and Ivax Corporation, which sold to Teva in 2005, creating the largest generic drug manufacturer in the world. After selling FCS, in 1997, Kenny invested through a venture firm he founded called Triumph. from 1997 through 2015, Triumph invested in micro to small public and private companies that showed promise in the fields of technology, oil and gas, biotech, and health care. Kenny became CEO of KORR Acquisitions Group, Inc. in 2015. KORR is an investment advisory and consulting company. Kenny passed The Uniform Investment Advisor Law Examination, Series 65, in 2015.
I invest with passion and conviction, and I have the strength to stick with an investment until my thesis plays out, hence "Courage & Conviction Investing." My greatest gift is a rare ability to synthesize public information on a stock to formulate conclusions the market hasn't even considered. I share this unique skill with subscribers to my Marketplace service, Market Adventures. High-conviction investing isn't for everyone, but if you're in the market to make serious money and you have an insatiable appetite for risk, and you're willing to wait patiently for potentially big gains, then Market Adventures might be the right fit for you.
“When you are inspired by some great purpose, some extraordinary project, all your thoughts break their bonds: Your mind transcends limitations, your consciousness expands in every direction, and you find yourself in a new, great and wonderful world. Dormant forces, faculties and talents become alive, and you discover yourself to be a greater person by far than you ever dreamed yourself to be.” (Author - Patanjali)
“Tentative efforts lead to tentative outcomes. Therefore, give yourself fully to your endeavors. Decide to construct your character through excellent actions and determine to pay the price of a worthy goal. The trials you encounter will introduce you to your strengths. Remain steadfast...and one day you will build something that endures: something worthy of your potential.” (Author - Epictetus)
"Hope sees the invisible, feels the intangible, and achieves the impossible." (Author - Unknown)
"When I stand before God at the end of my life, I would hope that I would not have a single bit of talent left, and could say, 'I used everything you gave me." (Author - Erma Bombeck)
I am a high school teacher for a decade. Before that I was an analyst (operations and financial) and for a short time a Controller I have a B.S. with an emphasis in Accounting and an MBA (for which I studied Finance, Economics, and Management) I passed the CPA exam on the first try and am a retired CPA in the state of Maryland. I have a high school teaching credential and an MA in Math Education
Occassionally write articles for Rida Morwa''s High Dividend Opportunities https://seekingalpha.com/author/rida-morwa/research
Occassionally write articles on Tag Oil for the Panick High Yield Report
Prior to co-founding Paul Kimmins Investments, LP, Paul was an executive in the Transaction Advisory Services team at Ernst & Young where he managed and reviewed asset valuation primarily for publicly traded Fortune 500 corporations. Prior to joining Ernst & Young, Paul was a Portfolio Manager within Key Private Bank, the wealth management arm of KeyBank. In this role, Paul personally managed and invested over $220 million across equities, fixed income and alternatives asset classes. In addition, Paul served as a voting member of the Equity Research Team, providing investment recommendation on the Energy, Technology, Utilities and Materials sectors.
Aside from free articles available to the general public, additional early-access, value-added ideas and deep-dive articles are offered to paid subscribers on my premium SA platform, "Retirement: One Dividend At A Time" . This exclusive RODAT Portfolio has performed even better than my popular FTG Portfolio, with higher dividend income growth and greater capital appreciation.
If you are interested in any of my digital utility solutions to add to your investing tool box to improve your investment outcomes, please visit my site
You'll find elegant applications that make it simple for you to track your portfolio in real time, make a watch list to follow in real time, track your dividend income and growth, and other applications. These applications will allow you to set alerts at prices you choose in order to obtain the yield and income that you want. They function as real time trade assistants and will improve your investment performance. You can even mirror the successful FTG Portfolio with "My FTG Mirror Calculator", and subscribers can mirror the premium subscriber portfolio with "MY RODAT Mirror Calculator" if they wish to emulate the out performance we've achieved in capital and income growth.
I am a retired clinical psychologist, and administrator and owner of a rehabilitation clinic we founded 40 years ago. For over 55 years I have managed several portfolios composed of investments accumulated over our professional careers. Since the financial crisis of 2008, I have employed specialized, customized dividend growth strategies aimed at enhancing and growing a dividend income stream.
Since December 24, 2014, I have demonstrated on Seeking Alpha the ongoing construction and portfolio management of the Fill-The-Gap Portfolio aimed at highlighting strategies investors may utilize to close the gap between an average Social Security benefit and the much greater costs faced in retirement.
This portfolio has outperformed all of the broad market indexes by a very wide margin, growing dividend income and total portfolio value consistently while the broader indexes struggle in negative territory all year.
Let me show you how to build and grow your portfolio and dividend income, step by step, towards a comfortable and secure retirement.
Robert Hauver, MBA, is a Registered Investment Advisor Representative., who publishes SA articles under the name
TipRanks rates DoubleDividendStocks in the Top 25 of all financial bloggers, and Seeking Alpha rates us in the Top 5 of several categories, including Dividend Ideas, Basic Materials, and Utilities.
We offer 2 investing services:
"Hidden Dividend Stocks Plus", a new Seeking Alpha Marketplace service, which focuses on undercovered and undervalued income vehicles. HDS+ scours the world's markets to find solid income opportunities with dividend yields ranging from 5% to 10%-plus, backed by strong earnings.
DoubleDividendStocks.com, an investment newsletter/website that features the best dividend stocks and option selling strategies for income investors looking to enhance their yields.
The https://www.DoubleDividendStocks.com website also features High Dividend Stocks By Sector Tables, Covered Calls and Cash Secured Puts Tables, a Dividend Stocks blog, and a a Stock Market News and Data pages. 845-225-4094
Fredrik Arnold is my pen name. In 2012 I retired from doing quality service analysis in Boston and moved to North Carolina in 2013. My fascination with capital preservation, long-term investments, and trading systems keeps me blogging for Seeking Alpha. My articles focus on dividend yields, analyst mean 1 yr targets, free cash flow yields, and one year total returns as stock trading indicators. These are essential tools for catching the most valuable dividend dogs. My dividend dogcatcher premium site in the Seeking Alpha Marketplace shows real-time trading results.
Andrew Left's Citron Research (http://www.citronresearch.com/) (formally known as Stocklemon.com) seeks to expose companies whose management is in some way misleading investors. Left digs into SEC filings, financials, management histories and other data to uncover such situations, and he is usually short the stocks he writes about. Mr. Left has been publishing for 7 years and has created a track record that is unrivaled in short selling. Mr. Left has been cited in Barron's, Wall St Journal, CNBC and other major publications repeatedly for his work. Mr. Left was also an invited speaker at the reknown Master Investor Conference.
Visit: Citron Research (http://www.citronresearch.com/)
Writing Style: I try to combine facts, analysis, and a touch of humour/story into my writing. It is my hope that this makes the topic of investing and securities for interesting while at the same time accurate and actionable.
Investing Style: I am an individual buy and hold investor. I believe an individual investing their own money's greatest advantage is patience. They do not have clients banging down the door for redemptions every time stocks decline nor do they have bosses, mandates, or other things that get in the way.
Passionate about profitable investing! Education: PhD - A Real Value Risk Estimation Model for an Emerging Market Experience: Investment manager at Let it grow investments, Netherlands Assistant professor at the University of applied sciences Amsterdam, Netherlands Data researcher at Bloomberg, London UK
Silicon Valley Insights provides investing suggestions in high quality, high growth equities with four decades of experience in both investing and growth company management. We have continuously covered the PC industry since its beginning from the time of the Apple IPO. And the internet sector since its beginning and the currently important smartphone, tablet, cloud computing and Big Data sectors from their beginnings. And most newly artificial intelligence and autonomous driving transportation although we covered AI in its early days before its many years of dormancy. The entire technology industry is covered with one team of investment professionals so that only the best investment recommendations from the sector are provided.
Our TipRank profile: https://www.tipranks.com/bloggers/hfir
HFI Research specializes in contrarian investment analysis. We help you to find clarity in a world of uncertainty. We take contrarian thinking very seriously and believe that the only way to obtain a real edge in the market is to possess a contrarian investment thesis. We share our investment analysis with premium subscribers through daily and weekly reports.
HFI Research Premium currently includes:
What Changed This Week - Our flagship weekly report that covers macro themes, energy equities, and other stock ideas we analyzed.
What Research Reports We Read This Week - Our weekly analysis of the research reports we read that week.
Daily Natural Gas Fundamentals - Our flagship daily natural gas fundamentals and weather update report (also offered by HFI Research Natural Gas).
Daily Pain - Our premium daily that discusses the ever changing market dynamic the team currently sees. Pain Capital writes this report for us.
Individual Stock Analysis - Subscriber only stock analysis and updates.
For more info, please message us.
Jeff is the President of NewArc Investments Inc., manager of both individual and institutional investments. Jeff is a registered investment advisor, and portfolio manager for NewArc's investment programs. Jeff is a former college professor with a hands-on, real world attitude. His quantitative modeling helped inform state and local officials in Wisconsin for more than a decade. A Public Policy analyst, he taught advanced research methods at the University of Wisconsin, and analyzed many issues related to state tax policy. Jeff began in the financial business as Research Director for trading firm at the Chicago Board Options Exchange. He investigated anomalies in the standard option pricing models, taught classes for beginning options traders, and developed new forecasting techniques. In 1991 he established a general research consultancy, working with professional traders at all of the Chicago financial exchanges. In 1998 he started NewArc Investments, Inc. Jeff has a commitment to the specific needs of individual investors. It is not a one-size-fits all approach, but one that emphasizes the unique circumstances of each client. Jeff also serves on the board of two small technology companies (currently Chairman at one). He is occasionally as an expert witness in legal cases involving financial markets and hedging.
Dr. Chris Kacher & Gil Morales run www.VirtueOfSelfishInvesting.com
Our VIX Volatility Model was up as much as +177.03% in 2016. After further debugging and improvements to the algo, it is up almost +15% in 2017 as of 1-13-17
Go here for results: https://www.virtueofselfishinvesting.com/market-timing-results/dr-k-vix-volatility-model/0
In 1995, Dr. Kacher operated one of the first Internet-based stock advisory services. He then went on to generate triple digit percentage returns for six years in a row during the 1995-2000 period before moving to cash for most of the 2000-2002 bear market, one of the worst in history. From 1996-2001, Dr. Kacher served as chief research analyst for William O'Neil + Company, the New York Stock Exchange member firm, institutional research provider, and publisher of Investor's Business Daily newspaper. During this period, William O'Neil hand-picked Dr. Kacher to manage a portion of the firm's proprietary capital, whereupon Dr. Kacher became a top internal portfolio manager at the company. Dr. Kacher received his B.S. in Chemistry and Ph.D. in Nuclear Physics from University of California at Berkeley, where he co-discovered Element 110 on the Periodic Table of Elements and confirmed the existence of Element 106 for which his team named Seaborgium after Dr. Glenn Seaborg, the inventor of plutonium, who supervised Dr. Kacher's work as a doctoral student at UC Berkeley. Musically gifted, Dr. Kacher was classically trained on the piano beginning at age 3, composing his first song at age 5 which he called "Night Fog," and performing as a concert pianist from ages 5 to 12 in high-profile cities in the US and Japan. He released his debut CD comprised of 21 original piano compositions in 2009. He, together with Gil Morales, recently co-authored a number of books including the bestseller "Trade Like An O'Neil Disciple: How We Made 18,000% in the Stock Market", published by John Wiley & Sons.
In the 1996 to 2002 period, Dr. Kacher achieved in his personal account a total return in excess of 18,000%, as verified by KPMG, the Big Four auditor here: http://s3.amazonaws.com/vosi/download/chris-kacher-kpmg-verification-letter.pdf
Dr. Kacher is also currently a principal and Managing Director of MoKa Investors, LLC and Virtue of Selfish Investing, LLC, www.virtueofselfishinvesting.com. He has been a frequent guest and commentator on MarketWatch.com, TownHall.com, CBS host Andy Giersher's Portfolio Doctor, and CNN News Radio's Wall Street Shuffle, among other venues.
Mr. Morales began his investment career in 1991 as a stockbroker in the Beverly Hills branch of Merrill Lynch. In 1994 he joined PaineWebber, Inc. where he quickly achieved Chairman's Club status as a top producer. In 1997, William O'Neil personally recruited Mr. Morales to join William O'Neil + Company, Inc. where he spent the next eight years as a Vice-President, internal Portfolio Manager responsible for managing a portion of the firm's proprietary assets, and Manager of the O'Neil Institutional Services group responsible for advising over 500 of the largest and most successful institutional investors in the world, including mutual fund, pension fund, and hedge fund clients. Mr. Morales also co-authored with William J. O'Neil a book on short-selling, "How to Make Money Selling Stocks Short," published by John Wiley & Sons in 2004. In 2004, Mr. Morales was appointed Chief Market Strategist for William O'Neil + Company, Inc. He, together with Chris Kacher, recently co-authored the book, "Trade Like An O'Neil Disciple: How We Made 18,000% in the Stock Market", published by John Wiley & Sons in 2010. He also contributed to the book, "Wiley Trading Guide, Volume II", published in 2011. In the period from January 1, 1998 to December 31, 2005, Mr. Morales achieved in his personal account a total return of 10,904.25% as audited by Rothstein Kass & Company, a hedge fund auditing firm . Applying a standard hedge fund 2%/20% fee structure to this return would yield a pro forma return of 5,572.04%, net of fees. Mr. Morales received his B.A. in economics from Stanford University. Mr. Morales is also currently a principal and Managing Director of MoKa Investors, LLC and Virtue of Selfish Investing, LLC, www.virtueofselfishinvesting.com. He has been a frequent guest and commentator on Fox Business News, MarketWatch.com, and CNN News Radio's Wall Street Shuffle and Opening Bell shows, among other venues. In 2010, Mr. Morales published "Trade Like an O'Neil Disciple - How We Made 18,000% in the Stock Market" (John Wiley & Sons) with his colleague and former O'Neil internal portfolio manager Dr. Chris Kacher.
Hello! I am the investment manager for Darkravenwind LLC, a small software development consulting firm. 20% of our pre-tax revenue is my responsibility to invest and grow. I also help moderate the "Value Investing" group on Facebook. My hobbies include fighting the Fed, martial arts, and old video games.
I first started using value investing techniques as first described by Benjamin Graham around 2005. I was wasting my life up to that point. My specialty, over and above corporate valuation, is analyzing people. Human behavior is remarkably consistent and can lead to huge gains when you understand what motivates them.
In my own portfolio, I have a diversified income focus with a preference for long term earnings and dividend growth. When a good opportunity comes along, I'll focus a large percentage of assets into that single holding. I'm also maintaining an income portfolio with a little over 180 high yielding companies inside of it as a bit of an experiment.
I am mostly self taught, but in 2008, I quadrupled my money in the crash, and saw numerous opportunities that I jumped on throughout the next few years. By 2012 my total portfolio was over 50,000% larger than when I had first started.
I was previously employed with Countrywide Financial Corp., and was present during the mortgage meltdown. I saw firsthand how the company was falling apart from the inside while management continued to believe the organization could be rescued. Because of that experience, I have made bond analysis and studying the effects of inflation a strong focus.
Market direction is irrelevant. I look for value. Profitable companies that are low or even fairly priced, so long as the results are dependable. Intrinsic value is subjective, but earnings power, and the strength of a brand reputation matters. I am absolutely fearless of the future and do not make political views a part of my investment process.
Additionally, I make frequent updates to a blog maintainted at WhoTrades called "Brand Power", you can read and subscribe to it at brandpower.whotrades.com.
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage.
The purpose of this profile is to allow us to share with our readers new transcript-related developments.
SA Transcripts Team
To all my followers I welcome you to my BlogSpot at SA....
You PAY nothing to me to learn what I know.. I give it to all FREELY and only ask that you pass it on in your own special way, especially if you MAKE MONEY!
I am now nearly 11 years retired from the US pharma industry having spent over 33 years in the Mid-Atlantic Corridor in Sales (Hospital mainly), Scientific Relations, Managed Care/LTC, than back into sales before retiring at age 55! It was always my Dream to retire Early and I achieved my Dream in May of 2007.
I started in 1974 around Christmas Time...US Pharma was the gift that kept giving to me for almost a Lifetime.I began my career 7 months out of College at tiny Reed and Carnrick, Kenilworth, NJ. We had HIGH double digit INFLATION and soaring Un employment in 1974! After 4 years of on the job learning and thank God for Michael Morse the best Division Sales Mgr I ever had, who believed in me when others thought I was too young and In-experienced, I developed into a Solid Pharma sales performer!
Others took notice and came calling in 1978, I left R&C and went to Hospital Sales at BMY for the next 4.5 years, than in 1983 Bayer/Miles Labs recruited me away, I stayed 25 years at Bayer until we merged into SGP/MRK prior to early retirement in 2007..
I was part of the launch of over 50 new drugs over my Career with 6 different Antibiotics including Azlocillin, Amikacin , Cipro and finally Avelox. The list included Antibiotics, Anti-Fungals, Anti High Blood Pressure/ Cholesterol, Anti-Neoplastics/Cancer, Immune Modulators, Dementia/AZ and Diabetes.etc. I like to say I sold drugs that treated people from WOMB to TOMB and I mean that quite literally!
Today I enjoy investing in Bio-Pharmas mostly, because it is what I know best! I come from the Peter Lynch School of Investing so only Invest in what you Know best!
I invest mostly 70% of portfolio in large companies such as AZN, BMY, PFE, MRK, GSK, and JNJ (love the divis and security) but I like the up and coming riskier Bios like EXEL,EXAS,CLDX, ARRY and many others. Cancer, Immunotherapy and Inflammation intrigues me most today--I call these disease states the FRUIT at the Top, pretty much all the Low hanging Fruit is now discovered and available Generically/relatively cheap too....so I have made those 3 Disease States a major Focus since 2008 w/ plays at PFE, JNJ,BMY,MRK and GSK...my best performing BTs are CRIS and EXEL, which have done quite well over time for me....today I see ARRY as a BT that reminds me so much of EXEL or CRIS a couple years ago....I am long ARRY and many others today!
As of 9/20/17 I am announcing a STRONG BUY on CRIS again....a stock Ive been invested in since 2010 w/ net profit booked of ~$68,000. CRIS is One of many incubators for Roche Holdings and Genentech..they are tiny but very nimble and worthy of risk money!
With the real fears of WW Pandemics and MDR-Bacteria, the FDA/Congress has given us BARDA,the GAIN act and QDIP and I've come to appreciate the Retroviral/Antibiotic/Anti-fungal cos.and have made them a major component of my LT strategy to build wealth while in Retirement....
Ive invested in AB cos like Trius(TSRX), Cubist(CBST), Cempra(CEMP-now Melinta), Durata(DRTX), Tetraphase(TTPH), Innovation(IPIX), Akaogen(AKAO),and Paratek(PRTK)....over the last couple years... I manage personal monies and some family members retirement monies..in total well over $1M ....gratis of course!
Just click on my Picture up in the Top left corner and you can always read my thoughts on a myriad of Pharmas and BTs..I think I have 900+ comments going back 10 years now!
I do not write articles for SA because their Editors do not believe in my Writing Style and I'm too old and unwilling to change for them for a lousy $35/article/penny per click payment so I Blog FREE instead! I give FREELY what others charge an ARM or a LEG for and many read me for just that reason, others for my wisdom and yet others for me experiences in Pharma..I try to keep it REAL WORLD when SA imo does not..in fact I think SA is a fraud promoter for much of their operation!
You may or may not agree w/ me in my postings but I will always tell you how I feel about Companies and I spare you the Noise and PC crap you may hear from others...mine is an opine that covers these Companies from the perspective of ONE who worked for/against them and over 33 years..today I am UN-encumbered by the BRIDLES of employment and PC , I can honestly look back at the those who did it right and wrong and share my thoughts w/ you honestly!